Clinical trial
Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2…
NCT00394407 · Emory University, Other · Completed
Key facts
| NCT number | NCT00394407 |
|---|---|
| Title | Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes |
| Official title | Comparative Trial Between Insulin Glargine Plus Supplemental Glulisine (Apidra) Versus Sliding Scale Regular Insulin In Hospitalized Patients With Type 2 Diabetes |
| Lead sponsor | Emory University, Other |
| Collaborators | Sanofi Industry University of Miami |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Hyperglycemia |
| Intervention type | Drug |
| Interventions | sliding scale regular insulin, glargine basal insulin and glulisine prandial insulin |
| Enrollment | 130 |
| Start date | Sep 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Nov 1, 2006 |
| Last update posted | Nov 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: